【レポートの概要（一部）】
1. Executive Summary
2. What are Biosimilars?
3. Emergence of Biosimilars
3.1 Role of the Biologics Price Competition and Innovation (BPCI) ACT
3.2 Issue of Data Exclusivity
4. Industry Definition
4.1 Defining Biosimilars
4.2 Specificity of Biosimilars
4.3 Categories of Biologics
4.4 Importance of Biosimilars
4.5 Comparing Biosimilars with Generics
4.6 Branded Product Business Model
5. Overview of the Biopharmaceutical Industry
5.1 Market Profile
5.2 Biopharmaceutical Manufacturing Process
6. Global Biosimilars Market Statistics
6.1 Market Profile
6.2 Market Size
6.3 Market Value of Branded Biologics Facing Patent Expiry
6.4 Operating Margin for Biosimilar Manufacturers
6.5 Investor Concerns regarding Biosimilars
6.6 Commercial Impact of the European Biosimilars Industry
7. Key Success Factors for Biosimilars
7.1 Long Term Strategy
7.2 Developing Competitive Intelligence
7.3 Proper Financial Structure
7.4 Developing Key Biomanufacturing Competencies
7.5 Developing Clinical Capabilities and Regulatory Expertise
7.6 Well Developed Sales and Distribution Channels
8. Factors Impacting the Global Biosimilars Industry
8.1 Growth of the Industry in Developed Countries
8.2 Growth of the Industry in BRIC Countries
8.3 High Cost of Biologics
8.4 Use of Branded Biologics to Increase
8.5 Introduction of Approval Pathways in the US and Japan
8.6 EU’s Draft on Biosimilar Monoclonal Antibody Guidance
8.7 Unfavorable Tendering Procedures
8.8 Problem of Reference Pricing
8.9 Strategy of Biosimilar Companies with Regards to Hospital and Retail Setting
8.10 Issue of Biosimilar Comparability
8.11 Lack of Incentives, Service Agreements and Marketing Costs
8.12 Availability of Second Generation Branded Biologics
8.13 No Automatic Substitution of Branded Biologics
8.14 Cost-containment to Boost Uptake of Biosimilars
8.15 Lack of Proper IP Protection in Emerging Countries
8.16 Ease of Market Entry in BRIC Countries
8.17 Strong Biologic Capabilities in BRIC Countries
8.18 Restricted Market Access for Domestic Players in Emerging Countries
8.19 Problem of Low Purchasing Power in Emerging Markets
9. Biosimilar Market Drivers & Challenges
9.1 Factors Driving Growth of Biosimilars
9.1.1 Need to Lower Healthcare Costs
9.1.2 Lower Development Costs of Biosimilars as compared to New Biologic Drug
9.1.3 Lower Cost of Treatment with Biosimilars
9.1.4 Upcoming Patent Expiries for Blockbuster Biologics
9.1.5 Large Sales of Biologic Drugs
9.1.6 Greater Profitability of Biosimilars as compared to Generic Drugs
9.2 Factors Restraining the Growth of Biosimilars
9.2.1 Lack of Automatic Substitution
9.2.2 High Cost of Development and Manufacturing as compared to Generics
9.2.3 High Entry Barriers to the Biosimilar Industry
9.2.4 Emergence of Second Generation Biologic Drugs
9.2.5 Patent Protection for Biologic Drugs
10. Regulatory Framework
10.1 Regulatory Framework in Europe
10.1.1 EMEA’s Current Position
10.1.2 Bolar Type Provision
10.1.3 Comparability Exercises
10.1.4 Approval Process for Biosimilars
10.2 Regulatory Framework in Japan
10.2.1 Current Position on Biosimilars
10.3 Regulatory Framework in the USA
10.3.1 BPCIA and the Approval Pathway for Biosimilars
10.3.1.1 Role of Biosimilarity and Interchangeability
10.3.1.2 FDA Regulations Biosimilars Approval and Regulation
10.3.1.3 Demonstration on Basis of Data
10.3.1.4 12 Years of Market and Data Exclusivity
10.3.1.5 Resolution to Patent Dispute
10.3.1.6 Notice of Commercial Marketing to Reference Product Sponsor
10.3.1.7 Substitution of Small Molecular Products
10.4 Differences between FDA & the EMEA
10.5 Issues with Momenta
11. Factors Determining Market Entry in the Global Biosimilar Industry
11.1 Long Drawn-out Biosimilar Clinical Development Timeline
11.2 Approval Pathways for Biosimilars
11.3 High Development Costs of Biosimilars
11.3.1 Costs in Developed Markets
11.4 Biosimilars Manufacturing in Developing Countries ? Pros & Cons
11.4.1 Issues with Regulatory Approval
11.4.2 Clinical Trials
11.4.3 Cost of Research & Development
11.4.4 Manufacturing Barriers
11.5 Proving of ‘Biosimilarity’
11.6 Issues with EMA Draft Guidelines for Biosimilar MAb Approval
11.7 Challenges with Patents
11.8 Role of Market Exclusivity for Branded Biologics
11.9 Strategic Partnerships Driving the Industry
11.9.1 Role of M&A Deals
11.9.1.1 Merck & Co.
11.9.1.2 Pfizer
11.10 Lack of Proper Safety Regulations
12. Biosimilar Approval Pathways in the US and Europe
13. Competitive Landscape
13.1 Key Industry Players
13.2 Key Industry Suppliers
13.3 Generic Drug Producers
13.4 Key Investors in the Industry
13.5 Major Stakeholders in the Industry
13.6 Developed versus Emerging Markets
13.7 Biosimilar Launches
13.8 Analysis by Markets
13.8.1 Biosimilars in Australia
13.8.2 Biosimilars in BRIC Countries
13.8.3 Biosimilars in the European Union (France, Germany, Italy, Spain, the UK)
13.8.4 Biosimilars in Japan
13.8.5 Biosimilars in United States
14. Analysis of Major Biosimilars
14.1 Epoetin
14.2 Filgrastim
14.3 Somatropin
15. Upcoming Patent Expiries and Opportunities for Biosimilars
16. Strategies of Big Pharma to Combat Biosimilars
17. Country-wise Biosimilar Market Analysis
17.1 France
17.1.1 Overview of the Healthcare System
17.1.2 Pricing and Reimbursement
17.1.3 Drivers & Challenges for Biosimilars in France
17.2 Germany
17.2.1 Overview of the Healthcare System
17.2.2 Pricing and Reimbursement
17.2.3 Drivers & Challenges for Biosimilars in Germany
17.3 India
17.4 Italy
17.4.1 Overview of the Healthcare System
17.4.2 Pricing and Reimbursement
17.4.3 Drivers & Challenges for Biosimilars in Italy
17.5 Japan
17.6 Spain
17.6.1 Overview of the Healthcare System
17.6.2 Pricing and Reimbursement
17.6.3 Drivers & Challenges for Biosimilars in Spain
17.7 United Kingdom
17.7.1 Overview of the Healthcare System
17.7.2 Pricing and Reimbursement
17.7.3 Drivers & Challenges for Biosimilars in the UK
17.8 United States
18. Major Industry Players
18.1 Dr. Reddy’s Laboratories Limited
18.1.1 Company Overview
18.1.2 Business Segments
18.1.3 Presence in Biosimilars Market
18.1.4 SWOT Analysis
18.2 Hospira Inc
18.2.1 Company Overview
18.2.2 Business Segments
18.2.3 Presence in Biosimilars Market
18.2.4 SWOT Analysis (Brief Analysis)
18.3 Sandoz International
18.3.1 Company Overview
18.3.2 Business Segments
18.3.3 Presence in Biosimilars Market
18.3.4 SWOT Analysis
18.4 STADA Arzneimittel AG
18.4.1 Company Overview
18.4.2 Business Segments
18.4.3 Presence in Biosimilars Market
18.4.4 SWOT Analysis
18.5 Teva Pharmaceutical Industries
18.5.1 Company Overview
18.5.2 Business Segments
18.5.3 Presence in Biosimilars Market
18.5.4 SWOT Analysis
18.6 Watson Pharmaceuticals
18.6.1 Company Overview
18.6.2 Business Segments
18.6.3 Presence in Biosimilars Market
18.6.4 SWOT Analysis
18.7 3SBio Inc.
18.8 Biocon Limited
18.9 Biopartners Gmbh
18.10 Celltrion Inc
18.11 Intas Biopharmaceuticals
18.12 Kyowa Hakko Kirin Co., Ltd.
18.13 Reliance Life Sciences
18.14 Shanghai Fosun Pharmaceutical (Group) Co., Ltd
18.15 Wockhardt
19. Global Biosimilars Market Outlook
19.1 Market Outlook
19.2 Forecast for Biosimilar Sales
19.3 Forecast for US Biosimilars Market
19.4 Forecast for European Biosimilars Market
19.5 Forecast for Japanese Biosimilars Market
19.6 Forecast for Biosimilars
19.6.1 Biosimilars for Monoclonal Antibodies against Cancer
19.6.2 Erythropoietin (EPO) Biosimilars Markets
19.6.3 Human Growth Hormone (hGH) Biosimilars Markets
19.6.4 Granulocyte ? Colony Stimulating Factor (G-CSF) Biosimilars Markets
19.6.5 Insulin and Insulin Analogs Biosimilars
19.6.6 Interferon alfa Biosimilars
19.6.7 Interferon beta Biosimilars
19.6.8 TNF alfa Inhibitor Biosimilars
20. Appendix
21. Glossary
【レポート販売概要】
■ タイトル：世界のバイオシミラー市場■ 英文：Global Biosimilars Industry
■ 発行日：2013年12月
■ 調査会社：Taiyou Research
■ 商品コード：TAYU40206057
■ 調査対象地域：世界
- 非極低温空気分離プラントの世界市場2018-2022About Non-cryogenic Air Separation Plants Non-cryogenic air separation plants are designed to produce gases like oxygen, nitrogen, and argon through various processes such as pressure swing technology, pressure swing adsorption, and membrane technology. The major end-users of such industrial gases are industries like metallurgy, chemicals, oil and gas, healthcare, paper and pulp, electronics, aero …
- 中国の見えない歯列矯正装置市場2016-2020About Invisible Orthodontic Braces Invisible orthodontic braces such as clear aligners, ceramic braces, and lingual braces are aesthetic products that are replacing the use of traditional devices including unattractive metal wires and braces. Invisible orthodontic braces help enhance self-esteem and physical confidence in people. Technavio’s analysts forecast the invisible orthodontics market in C …
- 世界主要国における卵巣癌（Ovarian Cancer）治療市場（～2020）Ovarian Cancer Therapeutics in Major Developed Markets to 2020 - Late-Stage Pipeline Focuses on Improved Progression Free-Surival and Targeted Therapies Summary GBI Research, has released the pharma report -"Ovarian Cancer Therapeutics in Major Developed Markets to 2020 - Late-Stage Pipeline Focuses on Improved Progression Free-Surival and Targeted Therapies". The current Ovarian cancer therapeuti …
- インテリジェントネットワークの世界市場：用途別（情報認識、トラフィック予測・分類、リソース管理・ネットワークの採択、パフォーマンス予測・コンフィギュレーションの外挿）、エンドユーザー別、サイズ別、地域別予測Global Intelligent Network Market to reach USD 10 billion by 2025. Global Intelligent Network Market valued approximately USD 1.16 billion in 2016 is anticipated to grow with a healthy growth rate of more than 27% over the forecast period 2017-2025. information cognition is expected to have a larger market share during the forecast period, as there is an increasing need for information cognition f …
- くる病治療の世界市場2019-2023About this market The growing awareness about vitamin D deficiency is one of the key factors expected to trigger market growth in the upcoming years. Rickets is often caused due to vitamin D deficiency in the body due to less exposure to the sun, dark skin, and the lack of vitamin D in the diet. Several programs are being initiated for creating public awareness about the health issues associated w …
- Black River Electric Cooperative, Inc.：発電所及びSWOT分析2013Black River Electric Cooperative, Inc. - Power Plants and SWOT Analysis, 2013 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (asset …
- Madalena Ventures Inc.：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Madalena Ventures Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Madalena Ventures Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential sour …
- 固定工具インサートの世界市場2017-2021ABSTRACTAbout Stationary Tool Inserts Stationary tool inserts used for cutting and shaping of metals and other materials were also developed as a part of the Industrial Revolution. These inserts ensure the effective manufacturing of critical and intricate components, with ease and utmost precision. These tool inserts form an indispensable part of machine tools that are either numerically or conven …
- 世界の整形外科用電動器具（医療機器）市場MediPoint: Orthopedic Power Tools - Global Analysis and Market Forecasts Summary A power tool is a key instrument in the armamentarium of the operating room for many orthopedic surgeries. The adoption rates for orthopedic power tools vary in different regions, mainly due to price sensitivity. Globally, and driven by the orthopedic industry’s continued innovation in cordless battery-powered systems …
- 航空機用ベアリングの世界市場予測（～2022年）：ころ軸受、玉軸受The aerospace bearings market is projected to grow from USD 7.88 Billion in 2016 to USD 11.19 Billion by 2022, at a CAGR of 6.01% during the forecast period. Factors such as increase in aircraft orders and deliveries across the globe, and upgradation of aircraft to reduce operational cost are the major growth factors for the aerospace bearings market. The market has been segmented on the basis of …
- Ecopetrol S.A.：石油・ガスの開発・生産動向及びコスト分析– Q1, 2013Ecopetrol S.A. Oil & Gas Exploration and Production Operations and Cost Analysis – Q1, 2013 Summary Ecopetrol S.A. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key opera …
- ホモジナイザーの世界市場：超音波ホモジナイザー、圧力式ホモジナイザー、機械式ホモジナイザーMarketsandMarkets projects that the market for homogenizers is projected to grow from USD 1.53 Billion in 2016 to USD 1.94 Billion by 2021, at a CAGR of 4.92%. The market for homogenizers is growing due to innovative developments in the industrial sectors and increasing demand from various end user industries such as food & dairy, cosmetics, pharmaceutical, biotechnologies, and chemical. Change in …
- 無人機（UAV）ペイロード/サブシステムの世界市場：C4I、レーダー、EW（電子戦）、EO（電気光学）、ソナーAbout UAV payloads and subsystems UAVs are aircraft controlled remotely by a pilot on the ground or by on-board computers. Payloads are one of the primary components of UAVs. These payloads are mounted below the UAVs and consist of various equipment depending on mission requirements. UAVs are being largely utilized in the military, civil, and commercial markets due to their low cost. Technavio's a …
- 果物・野菜成分の世界市場：濃縮、NFCジュース、ペースト、ピューレ、ピース、粉末The fruit & vegetable ingredients market is directly influenced by the growing processed food & beverage industry. The rise in consumption of bakery, confectionery, and dairy products in the developed economies is driving the market for fruit & vegetable ingredients. Busy work schedules demand on-the-go consumption and convenient meals. In addition to this, health and wellness consciousness among …
- 世界の赤外線検出器（IR Detector）市場動向及び予測（2013 – 2020）The IR detector technologies enable the systems that help to interact with the outer world without touching it. It mainly detects the radiations from the objects around it. This report gives a detailed analysis of these detection technologies, and their broad existing and emerging markets. The overall market for the IR detectors has been broadly classified into four major segments; namely by techn …
